IMBRUVICA Patient Assistance Program
Don’t let the cost of cancer treatment force impossible choices. We help eligible patients access Imbruvica (ibrutinib) for as little as $69.95 per month through manufacturer Patient Assistance Programs.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Imbruvica Is A Targeted Oral Cancer Therapy That Blocks BTK — Effective For CLL, SLL, Waldenström's Macroglobulinemia, And Chronic GVHD Without Traditional Chemotherapy
- Retail Price Is Approximately $9,690–$17,269/Month Without Insurance — Up To $207,000/Year For Continuous Treatment
- AffordMyPrescriptions Provides Access To Imbruvica For Just $69.95/Month Through The Patient Assistance Program
- No Generic Version Is Currently Available, Though Generic Entry May Occur In Late 2026 Or 2027 As Key Patents Expire
What is Imbruvica Prescription Assistance Program?
The Imbruvica Prescription Assistance Program is a manufacturer-sponsored initiative that provides Imbruvica at no medication cost to qualifying patients who cannot afford it. The program is available to uninsured and underinsured U.S. residents who meet income and residency requirements, and to Medicare Part D patients on a case-by-case basis. If approved, you receive your medication at no cost.
A blood cancer diagnosis upends your entire world — and discovering that the medication your oncologist prescribes costs $616 per tablet can make the financial devastation feel as overwhelming as the disease. Imbruvica is typically taken indefinitely, meaning the cost is an ongoing monthly burden that can total hundreds of thousands of dollars over treatment.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocateshandle every step of your enrollment.
Medicare Part D patients accepted. If you have Medicare Part D coverage, you may still qualify for the Patient Assistance Program through case-by-case exceptions.
Pharmacy Price Comparison
- Without Assistance, Imbruvica Costs Approximately $616 Per Tablet At Specialty Pharmacies. Discount Programs Provide Limited Relief For This Specialty Oncology Drug, But They Don't Come Close To What A Patient Assistance Program Provides, If You Qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$13,500.00 | Save ~$13430.05/mo |
| CVS Pharmacy | ~$13,800.00 | Save ~$13730.05/mo |
| Walmart | ~$13,200.00 | Save ~$13130.05/mo |
| Costco | ~$12,800.00 | Save ~$12730.05/mo |
| Drugs.com Best | ~$9,690.01 | Save ~$9620.06/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Imbruvica Prescription Program?
The Patient Assistance Program is free to apply for and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long-term solution:
Limitations of Coupons
- Specialty drug coupons offer limited savings on $9,690+/month medications
- Manufacturer copay card limited to commercial insurance only
- Cards expire and require constant renewal
- Still $9,690+/month even with best discount
- Can’t be used with Medicare or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of treatment phase or dose
- No expiration — continuous access as long as you qualify
- Medication shipped directly to your specialty pharmacy
- We manage all paperwork, refills, and renewals
- Medicare Part D patients accepted on case-by-case basis (2026 negotiated price: $9,319/month)
DO YOU QUALIFY?
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Imbruvica Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication At Current Pharmacy Prices
- You Have Medicare Part D Coverage (Accepted On Case-By-Case Basis)
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Imbruvica:
Imbruvica (ibrutinib) is a once-daily prescription oral medication for chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), Waldenström’s macroglobulinemia (WM), and chronic graft-versus- host disease (cGVHD) after failure of prior therapy. It is also approved for children age 1 and older with cGVHD. Available as tablets (140 mg, 280 mg, 420 mg, 560 mg), capsules (70 mg, 140 mg), and oral suspension. It is a specialty medication dispensed through specialty pharmacies.
How It Works:
Imbruvica targets cancerous B-cells in conditions like CLL and SLL by permanently blocking the BTK enzyme, which acts as a growth switch. By disabling this signaling pathway, the medication cuts off the “grow and survive” signals the cancer needs to multiply. This causes cancer cells to leave the bone marrow and lymph nodes and eventually die. A temporary rise in white blood cell counts often indicates the drug is successfully flushing cancer cells into the bloodstream.
Form and Use:
This medication is taken as a single dose once daily, at the same time each day, with a full glass of water. It is important to swallow the capsules whole; they should never be opened, broken, or chewed. Typically, patients continue this treatment indefinitely for as long as the cancer responds and the side effects remain tolerable.
Generic Availability:
While there is currently no generic version of Imbruvica available in the United States as of April 2026, several manufacturers have filed for FDA approval. Generic alternatives may emerge in late 2026 or 2027 following patent expirations, potentially lowering costs. Meanwhile, Medicare patients benefit from a negotiated price of $9,319 per month and a $2,000 annual out-of-pocket cap.
Warnings:
Imbruvica can lead to serious complications, including major bleeding, infections, heart rhythm issues like atrial fibrillation, and high blood pressure. Patients should disclose all current medications to their doctor and avoid consuming grapefruit or Seville oranges, which interfere with drug levels. It is vital not to stop treatment without medical advice, as doing so may cause the cancer to flare or progress.
FAQ (Frequently Asked Questions)
How Much Does Imbruvica Cost Without Insurance?
Imbruvica costs approximately $616 per tablet ($9,690–$17,269 per month depending on dose). For Medicare, the 2026 negotiated price is $9,319/month with a $2,000 annual out-of- pocket cap. ThroughAffordMyPrescriptions, qualifying patients receive Imbruvica at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Is This The Same Imbruvica I'd Get At A Pharmacy?
Yes. Imbruvica obtained through the Patient Assistance Program is the same FDA-approved tablet or capsule manufactured by the same company, dispensed through your specialty pharmacy.
Is There A Generic Version Of Imbruvica?
No. As of April 2026, no generic ibrutinib is available. Key patents are expiring in 2025–2027, with multiple manufacturers having filed FDA applications. A generic could potentially become available in late 2026 or 2027.
Can I Get Imbruvica Through The PAP If I Have Medicare?
Yes, on a case-by-case basis. Medicare Part D patients may also benefit from the 2026 negotiated price of $9,319/month combined with the $2,000 annual out-of-pocket cap. Our advocates help navigate every available pathway.
What If My Application Is Denied?
Our Patient Advocates immediately explore every alternative — including the manufacturer’s $0 copay assistance program (commercially insured), the Leukemia & Lymphoma Society, PAN Foundation, HealthWell Foundation, CancerCare copay assistance, Medicare Extra Help,insurance prior authorization appeals, and alternative BTK inhibitors like Calquence (acalabrutinib) or Brukinsa (zanubrutinib).
How Long Does It Take To Get Approved?
Approval typically takes 1–3 weeks. Because cancer treatment is time-sensitive, our advocates prioritize rapid processing and coordinate with your specialty pharmacy to minimize any delay in starting therapy.
Take Control of Your Medication Costs
If you are struggling with the high cost of Imbruvica, our team may be able to help you
access assistance programs designed to make medications more affordable. Check
your eligibility today and take the first step toward reducing your prescription costs.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.